LAWRENCE E GINSBERG to Aged
This is a "connection" page, showing publications LAWRENCE E GINSBERG has written about Aged.
Connection Strength
0.417
-
Styloid Process Osteoradionecrosis: Report of 3 Cases. J Comput Assist Tomogr. 2019 May/Jun; 43(3):472-474.
Score: 0.027
-
Pleural Metastasis in Head and Neck Cancer: Imaging Findings and Clinical Impact. J Comput Assist Tomogr. 2017 Mar/Apr; 41(2):249-253.
Score: 0.023
-
Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis. AJNR Am J Neuroradiol. 2013 Oct; 34(10):2005-9.
Score: 0.018
-
Perineural tumor spread along the nasociliary branch of the ophthalmic nerve: imaging findings. J Comput Assist Tomogr. 2013 Mar-Apr; 37(2):282-5.
Score: 0.017
-
Superimposed infection in mandibular osteoradionecrosis: diagnosis and outcomes. J Comput Assist Tomogr. 2012 Nov-Dec; 36(6):725-31.
Score: 0.017
-
Radiation-associated head and neck sarcomas: spectrum of imaging findings. Oral Oncol. 2012 Feb; 48(2):155-61.
Score: 0.016
-
Imaging of carotid canal sympathetic plexus schwannoma. AJNR Am J Neuroradiol. 2011 Aug; 32(7):1212-5.
Score: 0.016
-
Osteoradionecrosis of the hyoid bone: imaging findings. AJNR Am J Neuroradiol. 2010 Apr; 31(4):761-6.
Score: 0.014
-
Improving fat-suppressed T2-weighted imaging of the head and neck with 2 fast spin-echo dixon techniques: initial experiences. AJNR Am J Neuroradiol. 2009 Jan; 30(1):42-5.
Score: 0.013
-
Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. AJNR Am J Neuroradiol. 2008 Mar; 29(3):558-62.
Score: 0.012
-
Imaging characteristics of dacryocystocele diagnosed after surgery for sinonasal cancer. AJNR Am J Neuroradiol. 2007 Nov-Dec; 28(10):1872-5.
Score: 0.012
-
Nasal septal abscess in patients with immunosuppression. AJNR Am J Neuroradiol. 2007 Nov-Dec; 28(10):1878-9.
Score: 0.012
-
CT assessment of vocal cord medialization. AJNR Am J Neuroradiol. 2006 Sep; 27(8):1643-6.
Score: 0.011
-
Multi-detector row CT artifacts that mimic disease. Radiology. 2005 Sep; 236(3):756-61.
Score: 0.010
-
Clinical presentation and treatment of secondary orbital lymphoma. Ophthalmic Plast Reconstr Surg. 2002 Jul; 18(4):247-53.
Score: 0.008
-
MR imaging of leptomeningeal metastases: comparison of three sequences. AJNR Am J Neuroradiol. 2002 May; 23(5):817-21.
Score: 0.008
-
MR imaging of the muscular component of myocutaneous flaps in the head and neck. AJNR Am J Neuroradiol. 2001 Jan; 22(1):170-4.
Score: 0.008
-
Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology. 2000 Oct; 217(1):50-3.
Score: 0.007
-
The pterygopalatine fossa: postoperative MR imaging appearance. AJNR Am J Neuroradiol. 2000 Aug; 21(7):1315-9.
Score: 0.007
-
Great auricular nerve: anatomy and imaging in a case of perineural tumor spread. AJNR Am J Neuroradiol. 2000 Mar; 21(3):568-71.
Score: 0.007
-
Masticator space abnormalities associated with mandibular osteoradionecrosis: MR and CT findings in five patients. AJNR Am J Neuroradiol. 2000 Jan; 21(1):175-8.
Score: 0.007
-
Evaluating Perineural Spread to the Intratemporal Facial Nerve on Magnetic Resonance Imaging. Otolaryngol Head Neck Surg. 2019 06; 160(6):1087-1094.
Score: 0.007
-
Imaging of perineural tumor spread from palatal carcinoma. AJNR Am J Neuroradiol. 1998 Sep; 19(8):1417-22.
Score: 0.006
-
The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol. 1998 Apr; 49(4):436-40.
Score: 0.006
-
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8.
Score: 0.006
-
Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial. J Am Acad Dermatol. 2017 Dec; 77(6):1110-1113.e2.
Score: 0.006
-
Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751.
Score: 0.006
-
Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer. 2015 May 15; 121(10):1608-19.
Score: 0.005
-
CT findings in temporal bone osteoradionecrosis. J Comput Assist Tomogr. 2014 Sep-Oct; 38(5):662-6.
Score: 0.005
-
Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis. J Comput Assist Tomogr. 2014 Sep-Oct; 38(5):667-73.
Score: 0.005
-
MRI findings of myocutaneous and fasciocutaneous flaps used for reconstruction of orbital exenteration defects. Ophthalmic Plast Reconstr Surg. 2014 Jul-Aug; 30(4):328-36.
Score: 0.005
-
Imaging findings of recurrent tumors after orbital exenteration and free flap reconstruction. Ophthalmic Plast Reconstr Surg. 2014 Jul-Aug; 30(4):315-21.
Score: 0.005
-
Images in clinical medicine. Cerebral infarction. N Engl J Med. 1994 Jun 02; 330(22):1571.
Score: 0.005
-
Skull-base foramina of the middle cranial fossa: reassessment of normal variation with high-resolution CT. AJNR Am J Neuroradiol. 1994 Feb; 15(2):283-91.
Score: 0.005
-
CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma. AJNR Am J Neuroradiol. 2013 Sep; 34(9):1818-22.
Score: 0.004
-
MRI of Paget disease with temporal bone involvement presenting with sensorineural hearing loss. J Comput Assist Tomogr. 1992 Mar-Apr; 16(2):314-6.
Score: 0.004
-
Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e367-74.
Score: 0.004
-
Radiological pitfalls with laryngopharyngeal injectables. Laryngoscope. 2012 Feb; 122(2):307-10.
Score: 0.004
-
Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer. AJNR Am J Neuroradiol. 2011 Sep; 32(8):1532-8.
Score: 0.004
-
Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1205-11.
Score: 0.004
-
Imaging characteristics of primary laryngeal lymphoma. AJNR Am J Neuroradiol. 2010 Aug; 31(7):1261-5.
Score: 0.004
-
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):667-74.
Score: 0.004
-
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14.
Score: 0.003
-
Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread. Arch Ophthalmol. 2009 Aug; 127(8):1074-5.
Score: 0.003
-
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009 Jun; 32(3):274-9.
Score: 0.003
-
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009 Apr 20; 27(12):1976-82.
Score: 0.003
-
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck. AJR Am J Roentgenol. 2008 Dec; 191(6):W299-306.
Score: 0.003
-
Adenoid cystic carcinoma of the external auditory canal. Laryngoscope. 2008 Sep; 118(9):1591-6.
Score: 0.003
-
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003 Nov 15; 98(10):2214-23.
Score: 0.002
-
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30.
Score: 0.002
-
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002 Jan 15; 20(2):364-70.
Score: 0.002
-
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer. 2001 Nov 01; 92(9):2364-73.
Score: 0.002
-
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol. 2001 Jun 15; 19(12):3010-7.
Score: 0.002
-
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer. 2001 Apr 01; 91(7):1316-23.
Score: 0.002
-
The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):135-9.
Score: 0.002
-
Primary malignant tumors of the sphenoidal sinus. Neurosurgery. 2000 May; 46(5):1084-91; discussion 1091-2.
Score: 0.002
-
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Jun; 16(6):2221-32.
Score: 0.002
-
Allergic fungal sinusitis: CT findings. Radiology. 1998 May; 207(2):417-22.
Score: 0.002
-
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Apr; 16(4):1325-30.
Score: 0.002
-
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-33-S19-37.
Score: 0.002
-
Perineural spread of rhinocerebral mucormycosis. AJNR Am J Neuroradiol. 1996 Jan; 17(1):114-6.
Score: 0.001
-
Klippel-Feil syndrome: CT and MR of acquired and congenital abnormalities of cervical spine and cord. J Comput Assist Tomogr. 1993 Mar-Apr; 17(2):215-24.
Score: 0.001